2013 Career Mentors (Q-S)
University of Illinois
“Luck favors the prepared – be proactive about seeking out unique opportunities and building your network. You never know what might pop up!”
Dr. Jen Rice is a Technology Manager in the Office of Technology Management (OTM) at the University of Illinois Urbana-Champaign. As a Technology Manager, Dr. Rice manages the life science intellectual property portfolio of the University. Her responsibilities include working with University inventors to evaluate, market, and license their inventions, as well as educating the campus on the University’s technology transfer process and fostering corporate relationships. Dr. Rice also manages the OTM’s well renowned Commercialization Analyst Intern Program consisting of graduate students from business, law, and science.
Dr. Rice received her B.A. in Biochemistry and Molecular Biology from Boston University and her Ph.D. in Microbiology from the University of Illinois at Urbana-Champaign. During her doctoral studies, Dr. Rice investigated bacterial gene regulation by small RNAs under Dr. Carin K. Vanderpool and participated on the NIH Infection Biology Training Grant. Dr. Rice has presented her research at various scientific conferences throughout the world and has published her findings in top, peer reviewed journals. Dr. Rice joined the OTM in 2010 as a volunteer Commercialization Analyst while she was completing her Ph.D. studies. As a Commercialization Analyst, Dr. Rice assisted Technology Managers in assessing markets for new inventions, contributed to the evaluation of new technologies for patentability and licensing potential, and composed marketing materials. She joined the OTM as an Associate Technology Manager after defending her Ph.D. in 2011.
Vice President, Chemistry and Distinguished Fellow
Peter Senter joined Seattle Genetics in August 1998 and has served as Vice President, Chemistry since September 2002. In February 2009, Dr. Senter was recognized as the company’s first Distinguished Fellow. He leads Seattle Genetics’ chemistry department, which carries out research in antibody-drug conjugate technologies, including the development of potent drug payloads, novel linker systems, conjugation methodology and mechanism of action studies. Prior to joining the company, Dr. Senter was with Cytokine Networks, Inc., the Bristol-Myers Squibb Pharmaceutical Research Institute and the Dana-Farber Cancer Institute, Harvard Medical School. Dr. Senter received a Ph.D. in Chemistry from the University of Illinois, and an A.B. in Biochemistry from the University of California, Berkeley. He is the Senior Editor of Bioconjugate Chemistry and serves on the Editorial Board of four scientific journals. Dr. Senter is an Affiliate Professor of Bioengineering at the University of Washington. His research interests include targeted drug delivery, protein chemistry and biochemistry, and anti-cancer drug design. Dr. Senter has authored more than 130 scientific publications and holds more than 40 patents.
Professor of Law & Professor of Chemistry
“Leaving the lab does not make you a traitor. Once a chemist, always a chemist.”
Sean Seymore’s research focuses on how patent law should evolve in response to scientific advances and how the intersection of law and science should influence the formulation of public policy. Professor Seymore joined Vanderbilt’s law faculty in 2010, having previously taught at Washington & Lee University School of Law, where he was an assistant professor of law and earned the designations of Alumni Faculty Fellow and Huss Faculty Fellow for his scholarship and teaching. He was a visiting assistant professor at Northwestern University School of Law in 2007-08. Before law school, Professor Seymore held academic appointments in chemistry at Rose-Hulman Institute of Technology and Rowan University and was a visiting scientist at Indiana University-Bloomington. After earning his law degree, he practiced patent law with Foley Hoag in Boston. As an active member of the American Chemical Society (ACS), he served on the executive committee for the Division of Chemistry and the Law from 2009-2012, on the Committee on Patents and Related Matters from 2006-07 and on the Younger Chemists Committee from 2002-06. In spring 2012, Professor Seymore was appointed to the Program in Science, Technology, and Society at the Massachusetts Institute of Technology as a Dr. Martin Luther King Jr. Visiting Associate Professor.
Professor Seymore earned his B.S. in chemistry at the University of Tennessee as a Tennessee Scholar, an M.S.Chem. (with thesis) from the Georgia Institute of Technology, a Ph.D. in chemistry from the University of Notre Dame with an Arthur J. Schmitt Presidential Fellowship, and a J.D. from the University of Notre Dame with an Allen Endowment Fellowship. His dissertation, Polar Effects in Metal-Mediated Nitrogen and Oxygen Atom Transfer (see several novel compounds he synthesized), led to four peer-reviewed publications in Inorganic Chemistry, including a cover article.
Senior Vice President, Biology
“If you want to do science well, collaborate, collaborate, collaborate. Teamwork is critical, and other points of view contribute to better problem solving.”
Dr. Shaw established the Microbiology department at Trius Therapeutics and developed strategies for differentiating Tedizolid (a novel antibiotic which has completed Phase 3 clinical trials) from competitors through resistance studies. Prior to joining Trius, Dr. Shaw was Team Leader, Infectious diseases at Johnson & Johnson Pharmaceutical Research & Development (1999-2005) where she developed bacterial microarray technology for E. coli and S. aureus. She and her team utilized this technology to determine antibacterial mechanism of action and analyze bacterial pathogenesis. As a research fellow at Schering-Plough Research Institute (1984-1999) she initiated the use of genomic approaches for the discovery of novel antibacterial and antifungal agents. Dr. Shaw holds a B.S. in Biology from Brooklyn College, a Ph.D. in genetics from the University of Connecticut, and completed her postdoctoral fellowship at Washington University School of Medicine.
Dr. Shaw’s research interests are the development of novel antibacterial agents and the study of how bacterial resistance arises.
Managing Editor, ACS Chemical Biology
“I eagerly look forward to participating in this meeting.”
Dr. Soares received a B.Sc. degree in Microbiology and Biochemistry at St. Xavier’s College, Mumbai, India and an M.Sc. degree in Biochemistry at the University of Mumbai. In 2006, he received an M.S. degree in Microbiology and in 2008, a Ph.D. in Microbiology at The Ohio State University while working in a laboratory that discovered the 22nd genetically-encoded amino acid, L-pyrrolysine. Dr. Soares did post-doctoral work as a Research Associate at The Ohio State University, where he studied quorum sensing in pathogenic bacteria such as Salmonella and Escherichia. He joined the American Chemical Society in 2010 and is currently the Managing Editor of journals, ACS Chemical Biology.
Stevenson Professor of Chemistry
“Graduate school was more about learning about frustration rather learning about science.”
Gary A. Sulikowski received a B.S. in chemistry from Wayne State University and a Ph.D. degree in organic chemistry from the University of Pennsylvania under the direction of Professor Amos B. Smith, III. He was an American Cancer Society postdoctoral fellow at Yale University with Sam Danishefsky. His first faculty appointment was in the Department of Chemistry at Texas A&M University in 1991. He joined the Vanderbilt Chemistry Department as Professor of Chemistry and member of the Vanderbilt Institute of Chemical Biology beginning the 2004-2005 academic year. Sulikowski’s research area is organic and chemical biology. His research interests are in the development of synthetic strategies and methods, biomimetic synthesis and investigations into the biological properties of natural products. Sulikowski has received a number of fellowships and awards including an American Cancer Society Junior Faculty Fellow, an Alfred P. Sloan Fellowship, Association of Former Students of Texas A&M Teaching Award and an Eli Lilly Award. He was named a Texas A & M Faculty Fellow from 2002-2007, AAAS Fellow 2008 and he was awarded a Japan Society for the Promotion of Science Fellowship in 2003. He serves as Director of the VICB Synthesis Core and Vanderbilt Chemistry Biology Interface Training Program.
“Today’s scientist is a jack of all trades and a master of one”
Dr Sulikowski received her B.S. at Rosemont College (Rosemont, PA) in 1986. She went on to graduate studies in organic synthesis at the University of Pennsylvania and earned her Ph.D. in 1991 under the director of Amos B. Smith. She accepted a teaching position at Texas A&M University in 1991. She joined the faculty at Vanderbilt University in 2004 and in 2006 she completed a MS in Science Education.
Dr Sulikowski’s interest lie in teaching writing in the sciences and organic chemistry to undergraduates and is the 2008 recipient of the Harriet Gilliam Award for Teaching. In her role as the Associate Director of Education for the Vanderbilt Institute of Chemical Biology she fosters graduate student professional development. She is also the Program Director for the NSF-REU in Chemical Biology, the Certificate in Chemical Biology and acts as program co-coordinator for the CBI Training grant.